Matthew Akiyama, M.D., of Albert Einstein College of Medicine, discusses his new NIH grant to conduct a randomized clinical trial that will test strategies to limit COVID-19 spread among formerly incarcerated people.
Matthew Akiyama, M.D.
News — January 31, 2022—(BRONX, NY)—Prisons and jails have been fertile ground for COVID-19 outbreaks, leading to millions of cases in the United States. Individuals released from these facilities often transition to other congregate settings, such as homeless shelters and group homes, where COVID-19 infections can continue to spread. Now, and have been awarded a five-year, $3.4 million grant from the National Institutes of Health (NIH) to test a program aimed at reducing SARS- CoV-2 transmission among people recently released from incarceration.
The study will be led by , associate professor of at Einstein and an internist and infectious disease specialist at Montefiore. Dr. Akiyama will collaborate with , a New York City-based nonprofit serving both incarcerated and formerly incarcerated individuals, to conduct a randomized trial to assess an on-site, or “point-of-care” COVID-19 testing and education program.
Increased Risks for Formerly Incarcerated People
The Centers for Disease Control and Prevention (CDC) reports more than 715,000 total cases in U.S. correctional and detention facilities since March 31, 2020, although many note that is likely an undercount.
“People who are incarcerated face significant health disparities and an increased risk of SARS-CoV-2 infection,” said Dr. Akiyama, whose work focuses on illness among marginalized members of society. “Upon their release, many live in homeless shelters or congregate settings that are ripe for coronavirus transmission. Given the likelihood of COVID-19 remaining an endemic disease among high-risk populations, it’s important to test and establish effective strategies to reduce the virus’ spread in communities.”
Testing Approaches to Prevent COVID-19 Spread
The study will involve 250 people who have been released from prison or jail. All will receive education about the importance of testing for the virus. Half will be referred to offsite testing; the other half of participants will be offered rapid PCR tests every three months at The Fortune Society offices in Long Island City and Harlem. During the 30-minute wait for test results, justice-involved individuals trained as community health workers will provide one-to-one counseling about the importance of social distancing, proper hygiene, and mask-wearing. Travel to vaccine sites will be arranged and facemasks will be provided, if needed.
All participants will fill out questionnaires throughout the year. They also will receive smartphones to use for web-based surveys about their activities and how they are protecting themselves and others from the virus.
Dr. Akiyama is also partnering with the Einstein and Montefiore department of pathology to perform analyses that will indicate the specific variant of COVID-19 in those testing positive. “As variants like Omicron emerge, we’ll also have a system in place to monitor the variants that are circulating in the community,” said Dr. Akiyama. “I am thrilled to be collaborating with The Fortune Society as well as my colleagues in the division of general internal medicine, including Drs. Aaron Fox and Chenshu Zhang, and the department of pathology including Drs. Amy Fox and Yitz Goldstein to implement this study.”
The grant, “Leveraging community health workers to improve SARS-CoV-2 testing and mitigation among criminal justice-involved individuals accessing a corrections-focused community-based organization,” is funded by the National Institute on Minority Health and Health Disparities, part of the NIH (1R01MD016744).
***
About Albert Einstein College of Medicine
is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2020-21 academic year, Einstein is home to 732 students, 190 students, 120 students in the , and approximately 250 . The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its . In 2020, Einstein received more than $185 million in awards from the National Institutes of Health. This includes the funding of major at Einstein in cancer, aging, intellectual development disorders, diabetes, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with , the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. For more information, please visit , read our , follow us on , like us on , and view us on .
About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information, please visit . Follow us on and and , or view us on and .
RSS